0001662252-16-000299.txt : 20161223 0001662252-16-000299.hdr.sgml : 20161223 20161223135851 ACCESSION NUMBER: 0001662252-16-000299 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161220 FILED AS OF DATE: 20161223 DATE AS OF CHANGE: 20161223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xenetic Biosciences, Inc. CENTRAL INDEX KEY: 0001534525 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452952962 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVENUE, SUITE 230 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-778-7720 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE, SUITE 230 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: General Sales & Leasing, Inc. DATE OF NAME CHANGE: 20130227 FORMER COMPANY: FORMER CONFORMED NAME: GENERAL AIRCRAFT INC. DATE OF NAME CHANGE: 20111108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DEPTULA-HICKS DARLENE M CENTRAL INDEX KEY: 0001089409 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37937 FILM NUMBER: 162068734 MAIL ADDRESS: STREET 1: C/O ICAD, INC. STREET 2: 98 SPIT BROOK ROAD, SUITE 100 CITY: NASHUA STATE: NH ZIP: 03062 4 1 form4.xml OWNERSHIP DOCUMENT X0306 4 2016-12-20 0 0001534525 Xenetic Biosciences, Inc. XBIO 0001089409 DEPTULA-HICKS DARLENE M 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 1 0 0 0 Stock Option 3.50 2016-12-20 4 A 0 10000 0.00 A 2017-03-20 2026-12-20 Common Stock 10000 31416 D Stock Option 3.50 2016-12-20 4 A 0 10000 0.00 A 2017-06-20 2026-12-20 Common Stock 10000 41416 D Stock Option 3.50 2016-12-20 4 A 0 10000 0.00 A 2017-09-20 2026-12-20 Common Stock 10000 51416 D Stock Option 3.50 2016-12-20 4 A 0 10000 0.00 A 2017-12-20 2026-12-20 Common Stock 10000 61416 D On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the "Plan"). The Reporting Owner has the right to purchase 40,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option vests quarterly over twelve months. /s/ Darlene Deptula-Hicks 2016-12-22